FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Issue Open | February 15, 2023 |
Issue Close | February 28, 2023 |
Issue Size (Shares) | 0.94 Crores |
Issue Size (Amount) | ₹18.79 Crores |
Issue Price | ₹20 per Share |
Listing At | BSE |
September 18, 2024 12:37:00 AM
In July, the Senate Armed Services Committee passed its version of the FY 2025 National Defense Authorization Act (NDAA), which would make ...
Published by : JD SupraSeptember 10, 2024 7:48:00 PM
We leverage our global experiences, scientific expertise and operations knowledge to support policymakers in identifying policies that advance access to quality medicines and build systems that ...
Published by : CSR WireSeptember 10, 2024 4:20:00 PM
Two Japanese drugmakers and another in India were hit with Form 483s from the FDA following inspections that uncovered issues ranging from a lack of sanitary procedures to improper data collection and ...
Published by : FiercePharmaSeptember 10, 2024 7:33:00 PM
Nike shareholders have voted against a proposal to consider joining binding agreements with supply chain workers to better address human rights issues in high-risk countries at its annual meeting, the ...
Published by : ReutersRead Shukra Pharmaceuticals Rights Issue 2023 current news. Find Shukra Pharmaceuticals Rights Issue 2023 subscription news, Rights Issue analysis, broker reviews, allotment news, and listing date. Get the Shukra Pharmaceuticals Limited Rights Issue grey market premium and Shukra Pharmaceuticals Rights Issue 2023 expected listing price.
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|